Subscribe: EMM Alert: Biotechnology
http://press.jrc.it/rss?type=alert&id=Biotechnology&language=en
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
amo pharma  boards  cancer care  cancer  care  gene tumor  gene  new  san diego  therapy gene  tumor boards  tumor  ultra personal 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: EMM Alert: Biotechnology

Latest articles about Biotechnology



RSS feed from the corresponding page on http://emm.newsbrief.eu/NewsBrief



Last Build Date: Wed, 18 Oct 2017 09:45:32 CEST

 



The link between migraines and depression

Wed, 18 Oct 2017 09:45:00 +0200

In spite of the fact that about 12 percent of American adults experience migraines, according to the Migraine Research Foundation, the exact causes behind the acute headaches are not well understood. Migraines create the sensation of intense throbbing, and often are also marked by nausea, dizziness....



NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research

Wed, 18 Oct 2017 09:43:00 +0200

The overall objective of the research is to develop new therapeutic options for liver cancer by combining the cancer biology expertise at the Molecular Tumor Pathology, Division of Translational Cancer Research at Lund University and NeuroVive’s innovative drug discovery and development expertise.



AMO Pharma Presents Positive Interim Analysis of Data from Congenital Myotonic Dystrophy Study at American Neurological Association Annual Meeting

Wed, 18 Oct 2017 09:43:00 +0200

. AMO Pharma Presents Positive Interim Analysis of Data from Congenital Myotonic Dystrophy Study at American Neurological Association Annual Meeting. PR Newswire. LONDON and PHILADELPHIA, Oct. 18, 2017. “The interim analysis provides strong further support indicating that AMO-02 performs well....



Master of dragons' genetic code scoops nation's top science prize

Wed, 18 Oct 2017 09:38:00 +0200

Become a SMH member today! Create account now! Join today and you can easily save your favourite articles, join in the conversation and comment, plus select which news your want direct to your inbox. Professor Jenny Graves may not be a mother of dragons, but she is the master of their genetic code.



Master of dragons' genetic code scoops nation's top science prize

Wed, 18 Oct 2017 09:37:00 +0200

She analyses bearded dragons' genetic blueprint, or genome, and studies how, at higher temperatures, male eggs, with male genes, develop into females. Having fewer males could decimate the species under climate change, but there is also a human dimension.



Missouri court's ruling voids award in talc-powder suit

Wed, 18 Oct 2017 09:35:00 +0200

KANSAS CITY, Mo. -- A Missouri appeals court on Tuesday vacated a $72 million award to an Alabama woman who claimed her use of Johnson & Johnson products that contained talcum contributed to her ovarian cancer, throwing the fate of awards in similar cases into doubt.



Johnson & Johnson easily beats forecast for 3Q; earnings fall

Wed, 18 Oct 2017 09:35:00 +0200

Higher spending across the board drove Johnson & Johnson's third-quarter profit down 12 percent, despite a big sales jump fueled by recent acquisitions, hot new cancer drugs and strong sales of other key medicines. However, the health care giant easily topped Wall Street expectations.



Master of dragons' genetic code scoops nation's top science prize

Wed, 18 Oct 2017 09:35:00 +0200

Professor Jenny Graves may not be a mother of dragons, but she is the master of their genetic code. She analyses bearded dragons' genetic blueprint, or genome, and studies how, at higher temperatures, male eggs, with male genes, develop into females. Having fewer males could decimate the species....



Master of dragons' genetic code scoops nation's top science prize

Wed, 18 Oct 2017 09:35:00 +0200

She analyses bearded dragons' genetic blueprint, or genome, and studies how, at higher temperatures, male eggs, with male genes, develop into females. Having fewer males could decimate the species under climate change, but there is also a human dimension.



Ultra-personal therapy: Gene tumor boards guide cancer care

Wed, 18 Oct 2017 09:35:00 +0200

By MARILYNN MARCHIONE, AP Chief Medical Writer. SAN DIEGO Doctors were just guessing a decade ago when they gave Alison Cairnes' husband a new drug they hoped would shrink his lung tumors. Now she takes it too, but the choice was no guesswork. Sophisticated gene tests suggested it would fight her gastric cancer, and they were right.



Master of dragons' genetic code scoops nation's top science prize

Wed, 18 Oct 2017 09:34:00 +0200

She analyses bearded dragons' genetic blueprint, or genome, and studies how, at higher temperatures, male eggs, with male genes, develop into females. Having fewer males could decimate the species under climate change, but there is also a human dimension.



NORMA : Once Again Achieves Gold Status in the EcoVadis Sustainability Assessment

Wed, 18 Oct 2017 09:30:00 +0200

NORMA Group Once Again Achieves Gold Status in the EcoVadis Sustainability Assessment Maintal, Germany, October 18, 2017 - NORMA Group, a global market leader in engineered joining technology, ranks among the top five percent of all companies evaluated in the EcoVadis rating for the second consecutive time.



ExpreS2ion Biotech : new joint venture, AdaptVac, reaches proof of concept in animals for breakthrough breast cancer vaccine treatment

Wed, 18 Oct 2017 09:30:00 +0200

Hørsholm, Denmark, October 18, 2017 - Today, ExpreS2ion Biotech Holding AB ('ExpreS2ion') announces that its joint venture, AdaptVac ApS ('AdaptVac'), has reached proof of concept in advanced animal models (POCA) for AV-001, its novel vaccine treatment against breast cancer tumours.



NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research

Wed, 18 Oct 2017 09:29:00 +0200

LUND, Sweden , Oct. 18,2017 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that NeuroVive and Ramin Massoumi at Lund University have been granted 2.5 MSEK from the Swedish Foundation for Strategic Research (SFF)....



AMO Pharma Presents Positive Interim Analysis of Data from Congenital Myotonic Dystrophy Study at American Neurological Association Annual Meeting

Wed, 18 Oct 2017 09:29:00 +0200

LONDON and PHILADELPHIA Oct. 18, 2017 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, debilitating childhood onset neurogenetic disorders with limited or no treatment options, presented positive interim analysis of data from the first....



AMO Pharma Presents Positive Interim Analysis of Data from Congenital Myotonic Dystrophy Study at American Neurological Association Annual Meeting

Wed, 18 Oct 2017 09:28:00 +0200

LONDON and PHILADELPHIA Oct. 18, 2017 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, debilitating childhood onset neurogenetic disorders with limited or no treatment options, presented positive interim analysis of data from the first....



NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research

Wed, 18 Oct 2017 09:28:00 +0200

LUND, Sweden , Oct. 18, 2017 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that NeuroVive and Ramin Massoumi at Lund University have been granted 2.5 MSEK from the Swedish Foundation for Strategic Research (SFF)....



Cuban biotech royally connected in Thailand

Wed, 18 Oct 2017 09:28:00 +0200

Abinis received a ten-year tax holiday from the Board of Investment (BOI), compared with the usual five-year waiver, which is extendable by another three years based on the ratio of its R&D spending to earnings, as allowed under the new legislation. The revised BOI privileges were pushed through to....



Astra and Merck win speedy review for Lynparza in breast cancer

Wed, 18 Oct 2017 09:27:00 +0200

LONDON (Reuters) - U.S. regulators have granted a priority review to AstraZeneca's ovarian cancer drug Lynparza as a treatment for breast cancer, putting it on track for potential approval in the new disease area during the first quarter of 2018. The medicine, which is being jointly developed and....



Ovarian cancer could originate in the fallopian tubes, not the ovaries

Wed, 18 Oct 2017 09:27:00 +0200

Most and possibly all ovarian cancers do not start in ovaries but instead in the fallopian tubes , which are attached to them, claims a recent study. The new findings also point to the possibility that removing a woman’s fallopian tubes, but not her ovaries, may reduce risk of ovarian cancer in....



NHS waits for cancer care, A&E and ops worsen across UK

Wed, 18 Oct 2017 09:25:00 +0200

The BBC has looked at performance nationally as well as locally across the 135 hospital trusts in England and 26 health boards in the rest of the UK. Locally there is just one service in the whole of the UK - run by Luton and Dunstable NHS Trust - which has managed to hit all three targets each time over the past 12 months.



Updated Pocket Ks on Benefits of GM Crops

Wed, 18 Oct 2017 09:24:00 +0200

Updated versions of the following Pocket Ks are now available for download: Most of the updated information are based on the ISAAA Brief 52 and other reports with new data available. Pocket Ks are Pockets of Knowledge, packaged information on crop biotechnology products and related issues produced....



IPBO Fact Series on Cotton and Maize in Africa

Wed, 18 Oct 2017 09:24:00 +0200

The International Plant Biotechnology Outreach (IPBO) released two new Fact Series publications . The Facts Series titled Cotton in Africa reviews the impact of Bt cotton on African agricultural systems. It highlights the importance for donors and governments that invest heavily in the hope that GM....



Zygote injection of CRISPR-Cas9 Modifies the Target Gene without Unwanted Effects in Pigs

Wed, 18 Oct 2017 09:24:00 +0200

The editing tool has been instrumental in creating genetically modified pigs for use as biomedical or agricultural models. However, it is still unknown if the tool has an effect on the development of pig embryos. University of Missouri researchers led by Kristin Whitworth now aim to determine if....



Australian OGTR Receives Application for Commercial Release of GM Safflower

Wed, 18 Oct 2017 09:24:00 +0200

The Office of the Gene Technology Regulator (OGTR) has received a license application under the Gene Technology Act 2000 (the Act) for Dealings involving the Intentional Release (DIR) of genetically modified organisms (GMOs) into the Australian environment.



ITIF, Independent Scientists Call on US Interior Secretary to Reverse Policy Against GM Seeds

Wed, 18 Oct 2017 09:24:00 +0200

The Information Technology and Innovation Foundation (ITIF), one of the world's top science and technology body, together with a group of independent scientists, have submitted a letter to U.S. Interior Secretary Ryan Zinke to call on the department to reverse a Fish and Wildlife Service policy....



Biotechnology a Key Part of Uganda's Food Security Strategy

Wed, 18 Oct 2017 09:24:00 +0200

In a speech read for him by the 3 rd Deputy prime minister Hon. Kirunda Kivejinja, President Yoweri Museveni yet again highlighted the critical role of modern biotechnology in ensuring sustainable food and nutrition security for the country's 38 million people.



CSL moves to change CEO pay structure to avoid second strike from shareholders

Wed, 18 Oct 2017 09:23:00 +0200

While shareholders largely voted for the change, there were still critics. A dissident from the Australian Shareholders Association (ASA) said the board had set performance hurdles that were not very high, which meant executives would still be getting high-performance bonuses. Critics remain.



Ultra-personal therapy: Gene tumor boards guide cancer care

Wed, 18 Oct 2017 09:21:00 +0200

The Associated Press. Cancer patient Alison Cairnes poses for a portrait at the University of California San Diego in San Diego, Calif., on Aug. 15, 2017. Doctors were just guessing a decade ago when they gave Cairnes' husband a new drug they hoped would shrink his lung tumors. Now she takes it too, but the choice was no guesswork.



Astra and Merck win speedy review for Lynparza in breast cancer

Wed, 18 Oct 2017 09:18:00 +0200

LONDON (Reuters) - U.S. regulators have granted a priority review to AstraZeneca’s ovarian cancer drug Lynparza as a treatment for breast cancer, putting it on track for potential approval in the new disease area during the first quarter of 2018. The medicine, which is being jointly developed and....



Indian, Russian scientists craft gold nanostars to destroy cancer cells

Wed, 18 Oct 2017 09:16:00 +0200

Scientists from India and Russia have crafted star-shaped gold nanoparticles that can selectively destroy cancer cells. These stable, inexpensive and non-toxic particles will also make it possible to detect cancer at an early stage. The development was reported by scientists from the National....



The Hunt for the Brain-Eating Amoebas of Yellowstone

Wed, 18 Oct 2017 09:14:00 +0200

It was a lovely September day in Yellowstone’s Boiling River, which was not, in fact, boiling. Tourists trundled through the shallow water and dipped in where it was deeper. A herd of elk even waded through unconcerned. And among it all, a team of researchers in waders sampled the water for a....



Towards Good Palliation for Children with Cancer Recognizing the Family and the Value of Communication

Wed, 18 Oct 2017 09:08:00 +0200

Sammanfattning: Pediatric cancer imposes a threat on the child’s life and approximately every fifth child diagnosed with cancer will die due to his or her disease. The overall aim of this thesis was to explore palliative care of children with cancer and bereaved family members.



Ultra-personal therapy: Gene tumor boards guide cancer care

Wed, 18 Oct 2017 09:02:00 +0200

Cancer patients increasingly are having their care guided by molecular tumor boards, Experts study the patient's cancer genes and match treatments to mutations that seem to drive the disease. (October 18) Patient Alison Cairnes, left, looks at images with her doctor Shumei Kato, right, at the University of California San Diego in San Diego, Calif.



Ultra-personal therapy: Gene tumor boards guide cancer care

Wed, 18 Oct 2017 09:02:00 +0200

Cancer patients increasingly are having their care guided by molecular tumor boards, Experts study the patient's cancer genes and match treatments to mutations that seem to drive the disease. (October 18) Patient Alison Cairnes, left, looks at images with her doctor Shumei Kato, right, at the University of California San Diego in San Diego, Calif.



NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research

Wed, 18 Oct 2017 09:01:00 +0200

LUND, Sweden, Oct. 18, 2017 /PRNewswire/ -- NeuroVive Pharmaceutical AB (nasdaq stockholm:NVP)(otcqx:NEVPF), the mitochondrial medicine company, today announced that NeuroVive and Ramin Massoumi at Lund University have been granted 2.5 MSEK from the Swedish Foundation for Strategic Research (SFF)....



AMO Pharma Presents Positive Interim Analysis of Data from Congenital Myotonic Dystrophy Study at American Neurological Association Annual Meeting

Wed, 18 Oct 2017 09:01:00 +0200

Press Release AMO Pharma Presents Positive Interim Analysis of Data from Congenital Myotonic Dystrophy Study at American Neurological Association Annual Meeting. LONDON and PHILADELPHIA, Oct. 18, 2017 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company....



AstraZeneca cancer drug gets FDA priority review

Wed, 18 Oct 2017 09:01:00 +0200

AstraZeneca PLC (AZN.LN) on Wednesday said that the U.S. Food & Drug Administration has granted a priority review to its new drug application for tablets that treat breast cancer. The FTSE 100-listed pharmaceutical company said that the regulator will review its application by the first quarter of 2018.



Ultra-personal therapy: Gene tumor boards guide cancer care

Wed, 18 Oct 2017 09:00:00 +0200

Cancer patients increasingly are having their care guided by molecular tumor boards, Experts study the patient's cancer genes and match treatments to mutations that seem to drive the disease. (October 18) Patient Alison Cairnes, left, looks at images with her doctor Shumei Kato, right, at the University of California San Diego in San Diego, Calif.



Husband loses cancer battle just one month after getting married as new wife posts heartbreaking Facebook tribute

Wed, 18 Oct 2017 08:58:00 +0200

A newly-married man has lost his battle with inoperable cancer just a month after getting married and days after launching a fundraising campaign to pay for pioneering treatment. Paul Brame's new wife, Niah Phillips-Brame, wrote a heartbreaking Facebook post revealing that he had died from aggressive liver cancer on Saturday.



Ultra-personal therapy: Gene tumor boards guide cancer care

Wed, 18 Oct 2017 08:53:00 +0200

Cancer patient Alison Cairnes poses for a portrait at the University of California San Diego in San Diego, Calif., on Aug. 15, 2017. Doctors were just guessing a decade ago when they gave Cairnes' husband a new drug they hoped would shrink his lung tumors. Now she takes it too, but the choice was no guesswork.



Ultra-personal therapy: Gene tumor boards guide cancer care

Wed, 18 Oct 2017 08:44:00 +0200

SAN DIEGO (AP) — Doctors were just guessing a decade ago when they gave Alison Cairnes' husband a new drug they hoped would shrink his lung tumors. Now she takes it too, but the choice was no guesswork. Sophisticated gene tests suggested it would fight her gastric cancer, and they were right.



Without GMOs, South African maize yields would be lower

Wed, 18 Oct 2017 08:43:00 +0200

South Africa's maize crop, scorched this season by a blistering drought, would be in far worse shape if it were not for the country's embrace of genetically-modified (GMO) varieties and new farm technologies, an industry group said on Tuesday. South Africa's Agricultural Biotechnology Industry (ABI)....



Ultra-personal therapy: Gene tumor boards guide cancer care

Wed, 18 Oct 2017 08:36:00 +0200

By MARILYNN MARCHIONE AP Chief Medical Writer. SAN DIEGO (AP) - Cancer patients increasingly are having their care guided by molecular tumor boards, a new version of the hospital panels that traditionally decided whether surgery, radiation or chemotherapy would be best.



Flu vaccine supply is effective, Hong Kong health officials insist, as they urge public to get shots

Wed, 18 Oct 2017 08:36:00 +0200

. Hong Kong health officials on Tuesday renewed their effort to allay fears over the city’s supply of flu vaccines, saying there was no evidence that the World Health Organisation’s proposed alternative would offer better protection. Doctors from the Centre for Health Protection urged people....



Ultra-personal therapy: Gene tumor boards guide cancer care

Wed, 18 Oct 2017 08:34:00 +0200

SAN DIEGO (AP) — Doctors were just guessing a decade ago when they gave Alison Cairnes' husband a new drug they hoped would shrink his lung tumors. Now she takes it too, but the choice was no guesswork. Sophisticated gene tests suggested it would fight her gastric cancer, and they were right.



Ultra-personal therapy: Gene tumor boards guide cancer care

Wed, 18 Oct 2017 08:34:00 +0200

Cancer patients increasingly are having their care guided by gene tumor boards, a new version of the hospital panels that traditionally decided whether surgery, radiation or chemotherapy would be best. These experts study the patient's cancer genes and match treatments to mutations that seem to drive the disease.



Clonmel Cancer Support Centre to hold Winter Ball fundraiser

Wed, 18 Oct 2017 08:29:00 +0200

18 October 2017. A cancer support centre in Clonmel is hosting a Winter Ball. The CARE facility will hold the event on Friday 3rd November in the Hotel Minella. The event aims to raise funds for the centre, which provides care and support for cancer sufferer and their families.



Meet the winners of this year's Prime Minister's Prizes for Science

Wed, 18 Oct 2017 08:25:00 +0200

The awards, recognising Australia's top scientists and science teachers, have been announced in Canberra. The six winners share in a prize pool of $700,000. The end of the male sex chromosome? Did you know that the Y chromosome — which is carried by males — could be on the decline? That's one of the....